Chapter Seventeen: The Simpler Genetic Systems of Viruses and Bacteria

General Properties and Historical Discovery of Viruses

• Historical Discovery and Tobacco Mosaic Virus (TMV):

  • The first virus to be discovered was the tobacco mosaic virus (TMV).

  • TMV was initially characterized as a disease-causing, filtrable infectious agent.

  • Early researchers initially hypothesized that the infectious agent was a soluble chemical toxin.

  • Subsequent experimental work demonstrated that the agent multiplied inside the host plant rather than acting as a static poison.

• Nonliving Nature of Viral Particles:

  • Viruses are defined as nonliving particles that carry nucleic acid genomes enclosed within protective coats.

  • Viruses are classified as nonliving because they do not fulfill the fundamental criteria of living organisms:

  • They lack cellular organization (they are acellular and not composed of cells).

  • On their own, they cannot carry out metabolic pathways or utilize chemical energy.

  • They cannot independently maintain internal homeostasis.

  • They cannot reproduce on their own; viral replication strictly requires the uptake of the viral particle or its genetic material into a permissive host cell.

• General Diversity:

  • A virus is an infectious particle consisting of nucleic acid encased in a protein coat.

  • Thousands of virus species have been identified and classified by science.

  • Only a few hundred viral species are documented to cause infectious disease in humans.

  • Viruses display substantial diversity in their host ranges, overall structural morphologies, and genomic compositions.

Viral Structure, Morphology, and Genomic Diversity

• Virion Dimensions and Structural Anatomy:

  • Viral diameters range from approximately $20\,\text{nm}$ to $400\,\text{nm}$.

  • Capsid: All viruses contain a protein coat called a capsid that encloses and protects the viral nucleic acid genome.

  • The capsid is composed of protein subunits termed capsomers.

  • Capsid morphology varies widely, from simple helical cylinders to polyhedral (e.g., icosahedral) architectures.

  • Viral Envelope: Many animal viruses possess a lipid membrane envelope derived from the host cell's plasma membrane during viral exit.

  • Infection Mediators: Capsid proteins and envelope structures (such as projecting spikes) enable viruses to recognize, bind, and infect specific host cells.

  • Bacteriophages (Phages): Viruses that infect bacterial cells often feature complex capsids with accessory structures, including a polyhedral head, a central shaft, a base plate, and tail fibers specialized for host anchoring and nucleic acid injection.

• Genome Composition and Variations:

  • Viral genetic material is collectively termed the viral genome.

  • Viral genomes exhibit extraordinary variety compared to cellular genomes:

  • Nucleic acid type can be either DNA or RNA.

  • Strandedness can be single-stranded (ss) or double-stranded (ds).

  • Genome architecture can be linear or circular.

  • Genomes exhibit dramatic variations in nucleotide length and coding capacity:

  • The tobacco mosaic virus genome consists of single-stranded RNA of $6.4\,\text{kb}$ ($6400\,\text{base pairs}$) and contains only $6$ genes.

  • More complex viruses carry far larger genomes encoding dozens to hundreds of genes.

• Comparative Survey of Selected Viruses:

  • Phage $\lambda$ (Lambda):

  • Primary host: Escherichia coli (E. coli).

  • Effect on host: Can integrate harmlessly into the host chromosome or induce lytic cellular destruction.

  • Nucleic acid: Double-stranded DNA (dsDNA).

  • Genome size: $48.5\,\text{kb}$.

  • Number of genes: $36$.

  • Phage T4:

  • Primary host: E. coli.

  • Effect on host: Obligately induces host cell lysis.

  • Nucleic acid: Double-stranded DNA (dsDNA).

  • Genome size: $169\,\text{kb}$.

  • Number of genes: $288$.

  • Tobacco Mosaic Virus (TMV):

  • Primary host: Many species of plants.

  • Effect on host: Produces mottling, mosaic patterns, and tissue necrosis across leaves and other plant anatomy.

  • Nucleic acid: Single-stranded RNA (ssRNA).

  • Genome size: $6.4\,\text{kb}$.

  • Number of genes: $6$.

  • Baculoviruses:

  • Primary host: Insects.

  • Effect on host: Highly species-specific infections that typically kill the insect host.

  • Nucleic acid: Double-stranded DNA (dsDNA).

  • Genome size: $133.9\,\text{kb}$.

  • Number of genes: $154$.

  • Influenza Virus:

  • Primary host: Mammals.

  • Effect on host: Causes classical "flu" syndrome, characterized by high fever, cough, sore throat, and severe headache.

  • Nucleic acid: Single-stranded RNA (ssRNA).

  • Genome size: $13.5\,\text{kb}$.

  • Number of genes: $11$.

  • Coronavirus (SARS-CoV-2):

  • Primary host: Humans.

  • Effect on host: Causes COVID-19, characterized by fever, cough, fatigue, and severe acute respiratory manifestations.

  • Nucleic acid: Single-stranded RNA (ssRNA).

  • Genome size: $12\,\text{kb}$.

  • Epstein-Barr Virus:

  • Primary host: Humans.

  • Effect on host: Causes infectious mononucleosis accompanied by fever, sore throat, and pronounced fatigue.

  • Nucleic acid: Double-stranded DNA (dsDNA).

  • Genome size: $172\,\text{kb}$.

  • Number of genes: $80$.

  • Adenovirus:

  • Primary host: Humans.

  • Effect on host: Causes acute upper and lower respiratory symptoms and gastroenteritis/diarrhea.

  • Nucleic acid: Double-stranded DNA (dsDNA).

  • Genome size: $34\,\text{kb}$.

  • Number of genes: $35$.

  • Herpes Simplex Type 2:

  • Primary host: Humans.

  • Effect on host: Produces painful blistering lesions and sores around the genital anatomy.

  • Nucleic acid: Double-stranded DNA (dsDNA).

  • Genome size: $158.4\,\text{kb}$.

  • Number of genes: $77$.

  • Human Immunodeficiency Virus (HIV Type 1):

  • Primary host: Humans.

  • Effect on host: Causes acquired immunodeficiency syndrome (AIDS), a progressive collapse of cellular immune defense leading to fatal secondary complications if untreated.

  • Nucleic acid: Single-stranded RNA (ssRNA).

  • Genome size: $9.7\,\text{kb}$.

  • Number of genes: $9$.

  • Unit Conversion Note: In viral genomics, $1\,\text{kb}$ equals $1000\,\text{bases}$. Genome size and gene counts represent typical values among characterized strains.

Host Range and Pathophysiological Tropism

• Host Specificity Terminology:

  • Host Cell: An individual cellular unit that is actively infected and exploited by a virus.

  • Host Species: A biological species containing cells susceptible to infection by a given viral pathogen.

  • Host Range: The spectrum of host species and specific cell lineages that a given virus is capable of infecting.

• Range Dimensions:

  • Broad Host Range: Certain viruses infect a wide variety of distinct taxonomic species. Tobacco mosaic virus (TMV) infects numerous plant species across different families.

  • Narrow Host Range: Many viruses are strictly restricted to a single host species or exclusively target a defined cell type within that species.

• Receptors and Pathological Systems:

  • Host range and cellular tissue tropism are determined by molecular interactions between viral attachment proteins (capsid capsomers or spike glycoproteins) and specific host cell-surface receptor molecules.

  • Respiratory System Pathogens: Pathogens such as the influenza virus and human coronaviruses preferentially bind receptors on respiratory epithelial cells, causing acute respiratory disease.

  • Immune System Pathogens: HIV specifically targets helper T cells (CD4+ cells), progressively depleting these white blood cells and neutralizing adaptive immune responses.

  • Nervous System Pathogens: The rabies virus exhibits strict neurotropism, attacking neurons within the brain and peripheral nervous system.

  • Oncogenic Viruses: Human papillomavirus (HPV) infects mucosal and cutaneous epithelia and can drive neoplastic transformation, contributing directly to the development of cervical cancer.

  • Latent and Reactivating Pathogens: Herpesviruses establish latent reservoirs within specific tissues and reactivate periodically in response to physiological triggers.

The General Stages of Viral Reproductive Cycles

• Mechanisms of Viral Replication:

  • When an infectious virus invades a compatible host cell, viral gene expression initiates an ordered viral reproductive cycle that culminates in the assembly and liberation of progeny virions.

  • Cycles vary widely among different viral taxa, and even a single virus can switch between alternative reproductive pathways (such as lysogeny and lysis).

  • Despite this diversity, viral reproductive cycles share five or six fundamental phases:

• Phase 1: Attachment:

  • The virion collides with and binds specifically to the exterior surface of the permissive host cell.

  • Specificity is governed by chemical affinity between viral exterior proteins and host cell-surface proteins or receptor complexes.

• Phase 2: Entry:

  • The viral genetic material enters the host cell's internal environment.

  • Mechanism in Bacteriophages: The phage coat remains outside the cell while its genome is injected through the cell wall and membrane directly into the bacterial cytoplasm.

  • Mechanism in Enveloped Animal Viruses (e.g., HIV): The viral envelope fuses directly with the host plasma membrane, permitting the entire capsid core to enter the cytosol.

  • Pathway Diversion: Following entry, viruses capable of integration can either proceed to integration (Phase 3), thereby establishing latency and delaying virion production, or bypass integration directly to Phase 4 (synthesis of viral components) to mount an immediate productive infection.

• Phase 3: Integration:

  • Viruses capable of integration synthesize or package an enzyme called integrase.

  • Integrase introduces double-stranded cuts into the host chromosomal DNA and splices the viral genome directly into the host chromosome.

  • Prophage Formation: A bacteriophage genome integrated within a bacterial chromosome is designated a prophage. The ongoing replication of host cells harboring a prophage is called the lysogenic cycle.

  • Provirus Formation: An integrated viral genome inside a eukaryotic host chromosome is designated a provirus.

  • Retrovirus Mechanism: Retroviruses (such as HIV) possess an RNA genome. They utilize the enzyme reverse transcriptase to synthesize a single-stranded complementary DNA (cDNA) strand, followed by synthesis of a second strand to form double-stranded viral DNA before integration.

• Phase 4: Synthesis of Viral Components:

  • To produce new phage particles following a lysogenic phase, the prophage DNA must undergo prophage DNA excision from the bacterial chromosome.

  • Host enzymes, such as host DNA polymerase, synthesize multiple copies of the viral genome, while host RNA polymerase transcribes viral genes into messenger RNA (mRNA).

  • Expression of phage genes triggers rapid degradation of the host's chromosomal DNA, clearing host resources exclusively for viral propagation.

  • In retroviruses like HIV, the provirus is not excised from the host genome. Instead, it remains permanently embedded in the host chromosome, where host RNA polymerase transcribes it into multiple viral RNA transcripts that function both as mRNA for capsid/spike translation and as full-length viral genomes for progeny virions.

• Phase 5: Viral Assembly:

  • Newly synthesized genomic copies and structural proteins assemble into mature virions.

  • Self-Assembly: Genomes and capsomers of structurally simple viruses (such as TMV) self-assemble spontaneously without cellular or noncapsid assistance.

  • Directed Assembly: Morphologically complex viruses require noncapsid scaffolding proteins or enzymatic processing to guide capsid construction and genomic packaging.

• Phase 6: Release:

  • Nonenveloped phages synthesize the viral enzyme lysozyme, which degrades the bacterial peptidoglycan cell wall, inducing osmotic lysis and releasing progeny phages.

  • The reproductive series spanning steps 1, 2, 4, 5, and 6 is defined as the lytic cycle due to host cell destruction.

  • Enveloped animal viruses escape through budding, during which assembled capsids push outward through the host plasma membrane, acquiring an outer envelope studded with viral spike glycoproteins without immediate host cell lysis.

The Reproductive Cycle of Bacteriophage Lambda

• Step 1: Attachment:

  • Phage $\lambda$ specifically recognizes and binds to outer membrane protein receptors embedded in the cell envelope of Escherichia coli.

• Step 2: Entry:

  • Following attachment, the phage shaft contracts and injects the double-stranded linear phage DNA directly across the cell envelope into the E. coli cytoplasm, leaving the protein coat on the outside.

• Step 3: Integration and the Lysogenic Switch:

  • Once in the cytoplasm, the phage DNA circularizes.

  • The phage enzyme integrase cuts the circular E. coli chromosome and splices the phage $\lambda$ DNA into the bacterial genome.

  • The integrated viral DNA is termed a prophage.

  • The bacterium containing the prophage continues to survive, replicate its genome, and divide normally, duplicating the dormant prophage alongside its own chromosome across generations; this dormant reproductive cycle is known as the lysogenic cycle.

  • When triggered by environmental stress, prophage DNA excision occurs via excision enzymes, releasing the phage DNA from the chromosome and initiating the lytic cycle.

  • Alternatively, upon initial cell entry, phage $\lambda$ can bypass integration entirely and enter the lytic cycle directly at step 4.

• Step 4: Synthesis of Viral Components:

  • Once freed from the bacterial chromosome, the circularized phage DNA directs the host machinery to transcribe viral genes and translate phage structural and enzymatic proteins.

  • Host chromosomal DNA is degraded by viral nucleases, arresting host gene expression.

  • Host DNA polymerases replicate the phage DNA to generate numerous genomic copies.

• Step 5: Viral Assembly:

  • Newly synthesized phage heads, tails, and internal components are assembled.

  • Assembly of the complex icosahedral capsid head and attachment of the shaft and tail components is mediated by noncapsid scaffolding proteins.

  • Replicated phage DNA is packaged into the capsid head.

• Step 6: Release via Lysis:

  • Phage genes direct the synthesis of viral lysozyme.

  • Lysozyme digests the internal peptidoglycan bacterial cell wall from within.

  • The compromised cell wall ruptures under internal osmotic pressure (lysis), releasing assembled phage $\lambda$ progeny into the surrounding medium to infect adjacent bacterial cells.

The Reproductive Cycle and Pathogenesis of Human Immunodeficiency Virus

• HIV Structure and Biological Classification:

  • HIV is an enveloped, single-stranded RNA (ssRNA) retrovirus.

  • The internal core houses two identical copies of single-stranded viral RNA, alongside pre-packaged enzymes: reverse transcriptase and integrase.

  • The external viral envelope is a lipid bilayer embedded with protruding viral spike glycoproteins.

• Epidemiology and Modes of Transmission:

  • HIV is the causative agent of acquired immunodeficiency syndrome (AIDS).

  • AIDS was first recognized clinically in the year 1981 and represents one of the deadliest epidemics in human history.

  • Global mortality from AIDS has reached approximately $40\,\text{million}$ individuals worldwide.

  • More than $700,000$ AIDS-related deaths have occurred within the United States.

  • Approximately $1\,\text{in every }100$ adults between the ages of $15$ and $49$ is currently infected worldwide.

  • Transmission Routes:

  • Unprotected sexual contact with an infected individual.

  • Direct intravenous exposure via needle sharing among illicit drug users.

  • Vertical transmission from an infected mother to her child during pregnancy, labor, or delivery.

  • Evolutionary Origin: HIV evolved via zoonotic transmission from simian immunodeficiency virus (SIV), a closely related retrovirus that naturally infects nonhuman primate populations in Central and West Africa.

• Cellular Mechanism of Immunodeficiency:

  • HIV specifically infects and destroys helper T cells (CD4+ T lymphocytes), a white blood cell type essential for organizing mammalian adaptive immune defenses, including cytokine signaling and antibody production by B lymphocytes.

  • Gradual destruction of helper T cells compromises adaptive immunity, leaving patients vulnerable to opportunistic infections that rarely cause illness in healthy individuals.

  • A signature opportunistic complication of advanced HIV infection is severe pneumonia caused by the fungus Pneumocystis jirovecii, an organism that is readily cleared by an intact immune system.

• Step-by-Step HIV Replication Cycle:

  • Step 1: Attachment:

  • Viral spike glycoproteins projecting from the HIV envelope bind specifically to CD4 receptors (and coreceptors) on the host helper T cell plasma membrane.

  • Step 2: Entry and Uncoating:

  • Binding triggers fusion of the viral envelope directly with the host plasma membrane.

  • The viral capsid core enters the host cytosol.

  • Cellular enzymes degrade the outer capsid proteins in a process called uncoating, releasing viral RNA, reverse transcriptase, and integrase into the cytoplasm.

  • Step 3: Reverse Transcription and Integration:

  • Reverse transcriptase converts the single-stranded viral RNA genome into an intermediate RNA-DNA hybrid, digests the RNA template, and synthesizes a complementary DNA strand to yield double-stranded viral DNA.

  • Absence of Proofreading: Reverse transcriptase lacks $3' \rightarrow 5'$ exonuclease proofreading capability, introducing replication errors and generating frequent mutations in viral progeny.

  • This high mutation rate produces mutant strains resistant to host antibodies and antiretroviral therapies.

  • The double-stranded viral DNA is transported into the cell nucleus, where viral integrase splices it into the host chromosomal DNA, creating a provirus.

  • The integrated provirus can persist in a dormant state for extended periods.

  • Step 4: Synthesis of Viral Components:

  • Unlike prophages, the HIV provirus is never excised from the host genome.

  • Host RNA polymerase transcribes the proviral DNA into multiple copies of viral RNA.

  • These RNA transcripts exit the nucleus into the cytosol, where host ribosomes translate them into viral structural polyproteins and enzymes; other full-length transcripts serve as genomic RNA for new virions.

  • Step 5: Viral Assembly:

  • Capsid proteins assemble near the inner boundary of the host plasma membrane, enclosing two molecules of viral genomic RNA along with molecules of reverse transcriptase and integrase.

  • Capsid assembly coordinates with viral spike glycoproteins that have been translated and inserted into the host cell plasma membrane.

  • Step 6: Release via Budding:

  • Assembled viral cores push outward through the host cell plasma membrane.

  • The virions bud from the cell, acquiring an outer envelope derived directly from the host plasma membrane and enriched with viral spike glycoproteins.

  • Budding does not cause immediate host cell lysis, allowing the infected helper T cell to release virus particles over time before eventually dying.

• Antiretroviral Pharmacology:

  • Antiretroviral therapies have reduced annual AIDS deaths in the United States and globally by targeting essential steps in viral replication.

  • Reverse Transcriptase Inhibitors (e.g., Azidothymidine / AZT): AZT chemically mimics natural thymidine nucleotides; when incorporated by reverse transcriptase into elongating viral DNA, it causes chain termination and blocks cDNA synthesis.

  • Protease Inhibitors: Inhibit the viral protease enzyme required to cleave viral polyproteins into functional units, preventing mature capsid assembly and yielding non-infectious particles.

  • Therapeutic Challenges:

  • Designing drugs that selectively disable viral enzymes without disrupting host cellular enzymes and functions.

  • High mutation rates mediated by reverse transcriptase drive the emergence of drug-resistant HIV strains, necessitating combination therapy.

Viral Latency Mechanisms

• Biological Definition of Latency:

  • Viral latency is a reversible state in which a virus infects a host cell and maintains its genetic material without actively producing new virions or causing overt disease symptoms.

  • A latent infection can persist for months, years, or decades before reactivating to resume active viral synthesis.

• Mechanisms of Latency in Human Pathogens:

  • Mechanism 1: Proviral Chromosomal Integration:

  • The viral genome inserts directly into the host chromosomal DNA via integrase.

  • The virus remains integrated as a provirus, replicating alongside host DNA during cellular division while repressing viral gene expression.

  • Example: Human Immunodeficiency Virus (HIV).

  • Mechanism 2: Episomal Persistence:

  • Certain viruses do not routinely integrate into host chromosomes, instead maintaining their genomes in the host nucleus as episomes.

  • An episome is an extrachromosomal genetic element capable of autonomous replication alongside the host cell genome.

  • Herpes Simplex Type 1 (HSV-1): Establishes lifelong episomal latency within sensory nerve ganglia and periodically reactivates to cause cold sores around the oral epithelium.

  • Herpes Simplex Type 2 (HSV-2): Establishes latency in sacral nerve ganglia, reactivating to produce painful ulcerating lesions across the genital region.

  • Varicella-Zoster Virus (VZV): Causes chickenpox during primary acute childhood infection, enters lifelong latency within cranial and dorsal root ganglia, and can reactivate decades later as shingles (herpes zoster).

Emerging Viruses and Vaccine Platforms

• Dynamics of Emerging Viruses:

  • Emerging viruses are infectious agents that have newly appeared within a population or are expanding in geographic range, incidence, or pathogenicity.

  • Emerging viruses typically arise through spontaneous mutations in pre-existing viral genomes that alter host range, tissue tropism, or transmission efficiency.

  • Major emerging viral pathogens include:

  • Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2)

  • Influenza virus variants

  • Zika virus

  • Human immunodeficiency virus (HIV)

• Influenza Virus Mutability:

  • The influenza virus genome mutates frequently, generating novel strains that evade pre-existing human herd immunity.

  • H1N1 Variant: A prominent mutated strain responsible for the global "swine flu" outbreaks.

  • In the United States alone, seasonal influenza causes over $30,000$ deaths annually despite widespread annual vaccination programs.

• Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2):

  • SARS-CoV-2 is an enveloped, positive-sense single-stranded RNA virus that causes the clinical syndrome coronavirus disease 2019 (COVID-19).

  • The virus is phylogenetically linked to coronaviruses that naturally circulate in bat populations, though the exact intermediate zoonotic transmission route to humans remains unconfirmed.

  • The virion surface is characterized by prominent spike glycoproteins that project outward, creating a microscopic appearance resembling a solar corona.

  • Pandemic Declaration: On March 11, 2020, the World Health Organization (WHO) formally classified the global COVID-19 outbreak as a pandemic (defined as an epidemic that spreads across extensive international borders, infecting a high proportion of the human population).

  • Viral Evolution: Over time, natural selection favored SARS-CoV-2 strains with enhanced transmission efficiency and varying clinical severity in human hosts.

• Vaccinology and mRNA Vaccine Mechanisms:

  • Vaccine: A biological preparation that induces active acquired immunity against an infectious disease without causing full clinical illness.

  • Vaccination: The clinical administration of a vaccine into an individual.

  • The COVID-19 pandemic accelerated the development and deployment of synthetic mRNA vaccines.

  • Mechanism of mRNA Vaccines:

  • Synthetic mRNA sequences encoding the SARS-CoV-2 viral spike glycoprotein are encapsulated within synthetic lipid nanoparticles to prevent enzymatic degradation and facilitate cellular entry.

  • The vaccine formulation is administered via intramuscular injection, typically into the deltoid muscle of the arm.

  • Local skeletal muscle cells take up the lipid nanoparticles via endocytosis, releasing the mRNA into the cytoplasm.

  • Host ribosomes translate the mRNA into SARS-CoV-2 spike glycoproteins.

  • Synthesized spike proteins are processed and displayed on the muscle cell plasma membrane, where they are recognized by immune cells to stimulate neutralizing antibodies and protective immunological memory.